The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $21.50

Today's change0.00 0.00%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $21.50

Today's change0.00 0.00%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

Wright Medical Group NV closed at (U.S.)$21.50.

Over the last five days, shares have lost 1.38% and are down 11.08% for the last year to date. This security has underperformed the S&P 500 by 18.54% during the last year.

Key company metrics

  • Open(U.S.) $21.62
  • Previous close(U.S.) $21.50
  • High(U.S.) $21.62
  • Low(U.S.) $21.16
  • Bid / Ask-- / --
  • YTD % change-11.08%
  • Volume1,354,442
  • Average volume (10-day)1,596,204
  • Average volume (1-month)1,825,209
  • Average volume (3-month)1,352,753
  • 52-week range(U.S.) $15.02 to (U.S.) $25.84
  • Beta1.24
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.70
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-53.60%

Wright Medical Group NV has a net profit margin of -53.60%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 27, 201603/27/2016Dec 27, 201512/27/2015Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue1811697583
Total other revenue--------
Total revenue1811697583
Gross profit1291055965
Total cost of revenue52641619
Total operating expense2103408390
Selling / general / administrative1392555559
Research & development132356
Depreciation / amortization7544
Interest expense (income), net operating--------
Unusual expense (income)---732
Other operating expenses, total--------
Operating income-29-171-9-7
Interest income (expense), net non-operating-12-37-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-40-219-10-9
Income after tax-39-213-11-9
Income tax, total-1-611
Net income-48-273-11-9
Total adjustments to net income--------
Net income before extra. items-39-213-11-9
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-39-213-11-9
Inc. avail. to common incl. extra. items-48-273-11-9
Diluted net income-48-273-11-9
Dilution adjustment--------
Diluted weighted average shares1031124949
Diluted EPS excluding extraordinary itemsvalue per share-0.38-1.90-0.22-0.19
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.38-1.94-0.18-0.16